Preventive Strategies and Infectious Outcomes in Ruxolitinib-Treated Myeloproliferative Neoplasms. Mediterr J Hematol Infect Dis [Internet]. 2026 Apr. 30 [cited 2026 May 1];18(1). Available from: https://www.mjhid.org/mjhid/article/view/6334